Pura Vida Investments LLC Has Upped Holding in Merck & Co INC (MRK) by $3.49 Billion

January 22, 2018 - By Richard Conner

Investors sentiment decreased to 1.06 in Q3 2017. Its down 0.01, from 1.07 in 2017Q2. It dived, as 46 investors sold MRK shares while 619 reduced holdings. 106 funds opened positions while 598 raised stakes. 1.96 billion shares or 0.47% more from 1.95 billion shares in 2017Q2 were reported. Bb&T Secs Ltd Company holds 0.95% or 1.09 million shares. Parsons Cap Management Ri reported 99,874 shares. 21,330 are held by Pictet & Cie (Europe). Grace & White Incorporated New York, New York-based fund reported 27,225 shares. Moreover, Advisory Networks Ltd Liability Company has 0.29% invested in Merck & Co., Inc. (NYSE:MRK). Citigroup holds 0.13% of its portfolio in Merck & Co., Inc. (NYSE:MRK) for 2.43 million shares. Massachusetts-based Marble Harbor Investment Counsel Ltd Llc has invested 0.8% in Merck & Co., Inc. (NYSE:MRK). Tompkins Fincl owns 52,722 shares for 0.8% of their portfolio. Ahl Ptnrs Limited Liability Partnership has 0.15% invested in Merck & Co., Inc. (NYSE:MRK). Wealthtrust Axiom Ltd Limited Liability Company owns 1.24% invested in Merck & Co., Inc. (NYSE:MRK) for 50,712 shares. Andra Ap, Alabama-based fund reported 419,474 shares. Pathstone Family Office Ltd Liability stated it has 74,640 shares or 4.31% of all its holdings. Middleton And Inc Ma has 158,945 shares for 1.84% of their portfolio. Lvm Cap Mgmt Ltd Mi has invested 0.17% in Merck & Co., Inc. (NYSE:MRK). 57,654 are owned by Mai Cap Mgmt.

Pura Vida Investments Llc increased its stake in Merck & Co Inc (MRK) by 54.57% based on its latest 2017Q3 regulatory filing with the SEC. Pura Vida Investments Llc bought 54,570 shares as the company’s stock declined 2.46% while stock markets rallied. The institutional investor held 154,570 shares of the health care company at the end of 2017Q3, valued at $9.90 billion, up from 100,000 at the end of the previous reported quarter. Pura Vida Investments Llc who had been investing in Merck & Co Inc for a number of months, seems to be bullish on the $166.95 billion market cap company. The stock increased 0.25% or $0.15 during the last trading session, reaching $61.28. About 12.16 million shares traded. Merck & Co., Inc. (NYSE:MRK) has risen 16.86% since January 22, 2017 and is uptrending. It has outperformed by 0.16% the S&P500.

Pura Vida Investments Llc, which manages about $223.00 million and $199.58 billion US Long portfolio, decreased its stake in Gilead Sciences Inc (Put) (NASDAQ:GILD) by 20,000 shares to 30,000 shares, valued at $27.90M in 2017Q3, according to the filing. It also reduced its holding in Envision Healthcare Corp by 64,008 shares in the quarter, leaving it with 123,192 shares, and cut its stake in Biocryst Pharmaceuticals (Call) (NASDAQ:BCRX).

More notable recent Merck & Co., Inc. (NYSE:MRK) news were published by: Investorplace.com which released: “After Irrational Fire Sale, It’s Time to Buy the Dip in Merck & Co., Inc. Stock” on January 09, 2018, also Seekingalpha.com with their article: “Merck: Elucidating The Ramifications Of The Recent Keynote Findings” published on January 17, 2018, Investorplace.com published: “Merck & Co., Inc.’s Rally Could Burn Investors” on January 19, 2018. More interesting news about Merck & Co., Inc. (NYSE:MRK) were released by: Investorplace.com and their article: “Merck & Co., Inc. Stock Could Still Soar Another 10% From Here” published on January 18, 2018 as well as Nasdaq.com‘s news article titled: “Merck & Co. Inc. (MRK) Is Up Sharply On Phase 3 Study Results” with publication date: January 09, 2018.

Merck & Co., Inc. (NYSE:MRK) Ratings Coverage

Among 23 analysts covering Merck & Co. Inc. (NYSE:MRK), 16 have Buy rating, 0 Sell and 7 Hold. Therefore 70% are positive. Merck & Co. Inc. has $7400 highest and $50 lowest target. $66.44’s average target is 8.42% above currents $61.28 stock price. Merck & Co. Inc. had 73 analyst reports since August 13, 2015 according to SRatingsIntel. The stock of Merck & Co., Inc. (NYSE:MRK) has “Hold” rating given on Thursday, November 16 by Jefferies. As per Monday, October 30, the company rating was downgraded by Barclays Capital. Bank of America upgraded the shares of MRK in report on Thursday, October 13 to “Buy” rating. As per Friday, August 18, the company rating was maintained by Jefferies. As per Thursday, October 26, the company rating was maintained by Piper Jaffray. The firm has “Hold” rating given on Tuesday, October 31 by Jefferies. The firm has “Overweight” rating by Morgan Stanley given on Thursday, January 12. UBS maintained the shares of MRK in report on Monday, October 30 with “Buy” rating. On Monday, October 23 the stock rating was maintained by Leerink Swann with “Market Perform”. The rating was downgraded by Bank of America to “Neutral” on Wednesday, January 27.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.